Oliveira, R.Viegas, M. I.Abrantes, D.Conde, P. VazSaraiva, M.Espinheira, M. D. C.Trindade, E.Carvalho, I.Perdigoto, D.Sousa, H. Tavares deRoseira, J.2025-03-012025-03-012025-011873-99461876-4479http://hdl.handle.net/10400.1/26843The impact of coexistent IBD and PSC on disease progression and prognosis is unclear. This study evaluates outcomes in patients with both conditions, using the novel PSC Risk Estimate Tool (PREsTO) for PSC prognosis.engPredicting outcomes of disease in patients with primary sclerosing cholangitis and inflammatory bowel disease: a retrospective multicentric studyconference object10.1093/ecco-jcc/jjae190.0586